KG LEGAL \ INFO
BLOG

From Idea to Patent: Protecting Drone Technology in Poland, the EU and the United States

Publication date: November 18, 2026

Drones sit where mechanics, electronics, sensors and artificial intelligence meet, and the law that protects them sits at the same crossroads. Since around 20 Russian drones crossed into Polish airspace in September 2025, Europe has put drones and counter-drone systems at the top of its defence agenda, Poland has signed up for EUR 43.7 billion in EU defence loans, and the United States has closed its market to new foreign-made drones. In this environment the intellectual property behind a folding frame, a sensor array or an obstacle-avoidance algorithm can decide who wins contracts. This article explains what in a drone can be patented, how Polish, European and US law treat software and AI inventions, why patent classification, ISO standards and freedom-to-operate searches matter, and how EU and Polish drone regulation has changed over the past year.

What a patent is and what it requires

Polish statutes do not define the term “patent”, but legal scholarship fills the gap. The definitions vary in detail, yet they agree on the core: a patent is a time-limited exclusive right to exploit an invention commercially, granted by a decision of a competent state authority for its territory, in exchange for disclosure of the technical details of the invention. The system rests on a bargain between disclosing a technical solution to the public and granting its owner a temporary monopoly. In civil-law terms, a patent is an absolute right that allows its holder to use an intangible asset – the invention – to the exclusion of others.[1]

More

From Technology Transfer to Knowledge Valorisation: Managing Intellectual Assets under the EU Framework in 2026

Publication date: November 17, 2026

For almost two decades, European universities measured research impact in patents, licences and spin-offs. The EU has since moved the goalposts. Under Council Recommendation (EU) 2022/2415 and four codes of practice adopted in 2023-2024, the benchmark is now “knowledge valorisation”: turning all intellectual assets, from data and know-how to standards and citizen science, into economic and societal value. In 2025-2026 the policy began to harden into binding law, with the European Innovation Act proposed in September 2026, a European Research Area (ERA) Act in the pipeline and the next Framework Programme (FP10, 2028-2034) under negotiation. Polish universities, still operating largely on a 2008-era technology transfer model under the Law on Higher Education and Science, have a narrowing window to adapt.

More

Artificial Intelligence on Board: Are Polish and EU Law Ready for Cloud-Free Automotive AI?

Publication date: November 17, 2026

Legal status as of 12 November 2026

The automotive industry is increasingly turning to specialised companies from the artificial intelligence sector, and AI functions are moving from cloud servers to the vehicle’s own computers. This trend is currently most visible in the US market. From a Polish perspective, embedded in the EU legal order, the key question is whether existing rules allow such solutions to be deployed commercially and whether they support cooperation between manufacturers and academic spin-outs. The answer is yes, but on-device processing is not a regulatory shortcut: it changes how obligations are distributed, not whether they exist.

More

Thuringia Meets Małopolska: KG Legal KIELTYKA GLADKOWSKI at the Business Meeting with Minister-President Mario Voigt at SOLARIS

Publication date: November 17, 2026

Kraków, 17 November 2026

Today KG Legal is taking part in a business meeting with a delegation from the Free State of Thuringia, led by Minister-President Mario Voigt, hosted at the National Synchrotron Radiation Centre SOLARIS in Kraków. The meeting is organised by the Polish-German Chamber of Industry and Commerce (AHK Polska) together with the Marshal’s Office of the Małopolska Region and the Business in Małopolska centre, with LEG Thüringen, the Thuringian economic development agency, as a partner.

More

Ageing biomarkers as evidence of geroprotective efficacy

Publication date: November 10, 2026

Clinical research, diagnostic testing and commercialisation under Polish and EU law

Law as at 5 November 2026

Abstract

A change in an epigenetic clock may justify further investigation of a medicine. Its value as evidence of benefit depends on what the clock measures, the population in which it has been validated and whether treatment effects on the score predict effects on health. The same assay may be used to analyse archived samples, select participants for treatment or sell a test to consumers. Each use raises a different legal question. This article traces those questions from trial design through to commercial use, with particular attention to Polish law on medical experiments, performance studies, access to medical records and the use of data from non-commercial clinical trials.

Keywords  ageing biomarkers, geroprotectors, clinical trials, IVDR, biobanks, genetic data

More

UP